CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 7, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will …
Jetzt den vollständigen Artikel lesen